Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

406
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
406
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

548
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
548
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

1.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.8K
Hormonal Regulation01:33

Hormonal Regulation

32.8K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.8K
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

456
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
456
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

283
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
283

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteomic signatures of loss of glycemic control in youth-onset type 2 diabetes in the TODAY study.

The Journal of clinical endocrinology and metabolism·2026
Same author

Interdisciplinary development and application of computational methods in informatics for clinical applications.

Journal of the American Medical Informatics Association : JAMIA·2026
Same author

The Transparent Reporting and Evaluation of Artificial Intelligence Models (TRUE-AIM) Report Card: A Quality Assurance Initiative of the American Heart Association Journals to Promote High-Quality, Reproducible Artificial Intelligence Research.

Circulation·2025
Same author

Reduced-Order Model for Cell Volume Homeostasis: Application to Aqueous Humor Production.

Mathematical & computational applications·2025
Same author

scVAEDer: integrating deep diffusion models and variational autoencoders for single-cell transcriptomics analysis.

Genome biology·2025
Same author

Proteomic Analysis Uncovers Multiprotein Signatures Associated with Early Diabetic Kidney Disease in Youth with Type 2 Diabetes Mellitus.

Clinical journal of the American Society of Nephrology : CJASN·2024

Related Experiment Video

Updated: May 16, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K

A Heart-to-Heart With ChatGPT: AI Applications in Hypertension.

Anita Layton1,2,3,4

  • 1Department of Applied Mathematics, University of Waterloo, Waterloo, Ontario, Canada.

American Journal of Hypertension
|April 3, 2025
PubMed
Summary

Artificial intelligence (AI) offers new ways to understand and manage hypertension, a condition affecting cardiovascular health. AI tools like ChatGPT can improve patient care, diagnosis, and treatment by analyzing complex health data.

Keywords:
artificial intelligenceblood pressuredeep learninghypertensionlarge language modelsmachine learning

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.0K
Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

17.3K

Related Experiment Videos

Last Updated: May 16, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.5K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.0K
Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness
05:51

Measuring the Carotid to Femoral Pulse Wave Velocity Cf-PWV to Evaluate Arterial Stiffness

Published on: May 3, 2018

17.3K

Area of Science:

  • Cardiovascular Medicine
  • Medical Informatics
  • Artificial Intelligence in Healthcare

Background:

  • Hypertension significantly contributes to cardiovascular disease and mortality.
  • Optimal blood pressure control remains challenging due to disease heterogeneity and comorbidities.
  • Advancements in healthcare data necessitate novel analytical approaches.

Purpose of the Study:

  • To review the transformative impact of Artificial Intelligence (AI) on hypertension management.
  • To highlight the specific applications and potential of ChatGPT in hypertension research and clinical practice.

Main Methods:

  • Review of current literature on AI applications in hypertension.
  • Analysis of AI's role in data analysis, decision support, and patient education.
  • Focus on ChatGPT as a key AI tool.

Main Results:

  • AI is revolutionizing clinical practices, patient care, medical education, and research in hypertension.
  • ChatGPT demonstrates significant potential in enhancing data analysis and decision support.
  • AI facilitates improved patient education and engagement.

Conclusions:

  • AI, particularly conversational models like ChatGPT, holds immense potential to advance hypertension diagnosis and treatment.
  • Continued integration of AI is crucial for overcoming challenges in managing hypertension.
  • AI promises to personalize and optimize hypertension care pathways.